| Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ... Experimental parasitology 127 (3), 637-645, 2011 | 107 | 2011 |
| Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection D Doroud, F Zahedifard, A Vatanara, AR Najafabadi, Y Taslimi, ... Journal of controlled release 153 (2), 154-162, 2011 | 92 | 2011 |
| Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 79 | 2014 |
| Main quality attributes of monoclonal antibodies and effect of cell culture components F Torkashvand, B Vaziri Iranian biomedical journal 21 (3), 131, 2017 | 75 | 2017 |
| Designed amino acid feed in improvement of production and quality targets of a therapeutic monoclonal antibody F Torkashvand, B Vaziri, S Maleknia, A Heydari, M Vossoughi, F Davami, ... PloS one 10 (10), e0140597, 2015 | 70 | 2015 |
| A metabolic network-based approach for developing feeding strategies for CHO cells to increase monoclonal antibody production H Fouladiha, SA Marashi, F Torkashvand, F Mahboudi, NE Lewis, B Vaziri Bioprocess and Biosystems Engineering 43, 1381-1389, 2020 | 41 | 2020 |
| Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology S Aghaabdollahian, R Ahangari Cohan, D Norouzian, F Davami, ... Scientific reports 9 (1), 2978, 2019 | 27 | 2019 |
| Expression changes of cytoskeletal associated proteins in proteomic profiling of neuroblastoma cells infected with different strains of rabies virus F Zandi, N Eslami, F Torkashvand, A Fayaz, V Khalaj, B Vaziri Journal of medical virology 85 (2), 336-347, 2013 | 26 | 2013 |
| Generation of stable L. major+ EGFP-LUC and simultaneous comparison between EGFP and luciferase sensitivity T Taheri, HS Nik, N Seyed, F Doustdari, MH Etemadzadeh, ... Experimental parasitology 150, 44-55, 2015 | 24 | 2015 |
| C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice D Doroud, F Zahedifard, A Vatanara, Y Taslimi, R Vahabpour, ... PLoS neglected tropical diseases 5 (7), e1236, 2011 | 24 | 2011 |
| Improvement of Certolizumab Fab′ properties by PASylation technology S Mazaheri, Y Talebkhan, F Mahboudi, L Nematollahi, RA Cohan, ... Scientific Reports 10 (1), 18464, 2020 | 17 | 2020 |
| Comparative proteomics analysis of mice lymphocytes in early stages of infection by different strains of rabies virus B Vaziri, F Torkashvand, N Eslami, A Fayaz Indian journal of virology 23, 311-316, 2012 | 14 | 2012 |
| Identification of proteins derived from Listeria monocytogenes inducing human dendritic cell maturation R Mirzaei, A Saei, F Torkashvand, B Azarian, A Jalili, F Noorbakhsh, ... Tumor Biology 37, 10893-10907, 2016 | 7 | 2016 |
| Computational engineering of protein L to achieve an optimal affinity chromatography resin for purification of antibody fragments S Rahmati, F Torkashvand, M Amanlou, K Bagherzadeh, P Fard Esfahani, ... Analytical Chemistry 93 (46), 15253-15261, 2021 | 6 | 2021 |
| Quantitative proteomic analysis of cellular responses to a designed amino acid feed in a monoclonal antibody producing Chinese hamster ovary cell line F Torkashvand, F Mahboudi, M Vossoughi, E Fatemi, SMM Basri, ... Iranian Biomedical Journal 22 (6), 385, 2018 | 5 | 2018 |
| Optimization of culture conditions for high-level expression of soluble and active tumor necrosis factor-α in E. coli S Damough, M Sabzalinezhad, Y Talebkhan, L Nematollahi, E Bayat, ... Protein Expression and Purification 179, 105805, 2021 | 4 | 2021 |
| In vivo evaluation of carvedilol cardiac protection against trastuzumab cardiotoxicity E Beiranvand, SN Ostad, EM Ardakani, F Torkashvand, S Sardari, B Vaziri Drug Research 70 (04), 165-169, 2020 | 4 | 2020 |
| Effect of Cysteamine on cell growth and IgG4 production in recombinant Sp2. 0 cells H Jahandar, B Vaziri, L Nematollahi, T Afsharirad, E Mirabzadeh, ... Iranian Journal of Pharmaceutical Research: IJPR 14 (1), 177, 2015 | 4 | 2015 |
| Charge Variants Analysis of Recombinant Monoclonal Antibodies F Torkashvand, B Vaziri Biomedical Journal of Scientific & Technical Research 20 (1), 14766-14767, 2019 | 3 | 2019 |
| Quality by design in downstream process development of romiplostim S Pouri, F Torkashvand, HA Moghim, P Fard-Esfahani, M Golkar, B Vaziri Iranian biomedical journal 26 (6), 414, 2022 | 2 | 2022 |
